SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Nvidia Options Price in $280 Billion Earnings Swing 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Add as a preferred source on Google
BURLINGTON, Mass., April 18, 2018 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2018 financial results on Wednesday, April 25, 2018, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 1197775. The call can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc.
Steven Chehames
Investor Relations
+1-781-425-1659
[email protected]
http://www.lemaitre.com
LeMaitre Vascular, Inc.
